flag stub1 (Sino Biological)
Sino Biological is a verified supplier 
Sino Biological manufactures this product 
93
Structured Review
Sino Biological
flag stub1
Flag Stub1, supplied by Sino Biological, used in various techniques. Bioz Stars score: 93/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/flag+stub1/Human+STUB1+Gene+ORF+cDNA+clone+expression+plasmid%2C+N-Flag+tag/pmc12625700-52-7-10
Average 93 stars, based on 4 article reviews
Flag Stub1, supplied by Sino Biological, used in various techniques. Bioz Stars score: 93/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/flag+stub1/Human+STUB1+Gene+ORF+cDNA+clone+expression+plasmid%2C+N-Flag+tag/pmc12625700-52-7-10
Average 93 stars, based on 4 article reviews
flag stub1 - by Bioz Stars,
2026-09
93/100 stars
Images
Related Articles
Transfection:Article Title: Allosteric inhibition of HSP70 in collaboration with STUB1 augments enzalutamide efficacy in antiandrogen resistant prostate tumor and patient-derived models. Article Snippet: .. Cells were transiently transfected with plasmids expressing AR-FL [28], AR-V7 [28], Article Title: Proteostasis perturbation of N-Myc leveraging HSP70 mediated protein turnover improves treatment of neuroendocrine prostate cancer Article Snippet: .. Cells were transiently transfected with plasmids expressing HA-N-Myc (Addgene, Catalog#74163), His-N-Myc (SinoBiological, Catalog# HG17471-CH), Article Title: Allosteric inhibition of HSP70 in collaboration with STUB1 augments enzalutamide efficacy in antiandrogen resistant prostate tumor and patient-derived models Article Snippet: .. Cells were transiently transfected with plasmids expressing AR-FL [ ], AR-V7 [ ], Expressing:Article Title: Allosteric inhibition of HSP70 in collaboration with STUB1 augments enzalutamide efficacy in antiandrogen resistant prostate tumor and patient-derived models. Article Snippet: .. Cells were transiently transfected with plasmids expressing AR-FL [28], AR-V7 [28], Article Title: Proteostasis perturbation of N-Myc leveraging HSP70 mediated protein turnover improves treatment of neuroendocrine prostate cancer Article Snippet: .. Cells were transiently transfected with plasmids expressing HA-N-Myc (Addgene, Catalog#74163), His-N-Myc (SinoBiological, Catalog# HG17471-CH), Article Title: Allosteric inhibition of HSP70 in collaboration with STUB1 augments enzalutamide efficacy in antiandrogen resistant prostate tumor and patient-derived models Article Snippet: .. Cells were transiently transfected with plasmids expressing AR-FL [ ], AR-V7 [ ], Article Title: Stabilization of RUNX1 Induced by O-GlcNAcylation Promotes PDGF-BB-Mediated Resistance to CDK4/6 Inhibitors in Breast Cancer Article Snippet: The antibodies against phospho-Rb (Ser 807/811) (Cell Signaling Technology Cat# 8516, RRID:AB_11178658), total-Rb (Cell Signaling Technology Cat# 9309, RRID:AB_823629), phosphor-Akt (Ser473) (Cell Signaling Technology Cat# 4060, RRID:AB_2315049), total-Akt (Cell Signaling Technology Cat# 9272, RRID:AB_329827), p21 (Cell Signaling Technology Cat# 2947, RRID:AB_823586), GAPDH (Cell Signaling Technology Cat# 2118, RRID:AB_561053), β-Actin (Cell Signaling Technology Cat# 3700, RRID:AB_2242334), PARP (Cell Signaling Technology Cat# 9532, RRID:AB_659884), OGT (Cell Signaling Technology Cat# 24083, RRID:AB_2716710), His-tag (Cell Signaling Technology Cat# 12698, RRID:AB_2744546), FLAG-tag (Cell Signaling Technology Cat# 14793, RRID:AB_2572291), Myc-tag (Cell Signaling Technology Cat# 2276, RRID:AB_331783), HA-tag (Cell Signaling Technology Cat# 3724, RRID:AB_1549585), Cyclin D1 (Cell Signaling Technology Cat# 55506, RRID:AB_2827374), RUNX1 (Cell Signaling Technology Cat# 4336, RRID:AB_10859035) were all from Cell signaling technology; the antibody against PDGFB (Santa Cruz Biotechnology Cat# sc-365805, RRID:AB_10848458) was from Santa Cruz; the antibodies against O-GlcNAc (RL2) (Abcam Cat# ab2739, RRID:AB_303264) and RUNX1 (Abcam Cat #ab240639) were from Abcam. .. Plasmid expressing HA-RUNX1 RRID:Addgene_181980 was from Addgene; Plasmid Preparation:Article Title: Stabilization of RUNX1 Induced by O-GlcNAcylation Promotes PDGF-BB-Mediated Resistance to CDK4/6 Inhibitors in Breast Cancer Article Snippet: The antibodies against phospho-Rb (Ser 807/811) (Cell Signaling Technology Cat# 8516, RRID:AB_11178658), total-Rb (Cell Signaling Technology Cat# 9309, RRID:AB_823629), phosphor-Akt (Ser473) (Cell Signaling Technology Cat# 4060, RRID:AB_2315049), total-Akt (Cell Signaling Technology Cat# 9272, RRID:AB_329827), p21 (Cell Signaling Technology Cat# 2947, RRID:AB_823586), GAPDH (Cell Signaling Technology Cat# 2118, RRID:AB_561053), β-Actin (Cell Signaling Technology Cat# 3700, RRID:AB_2242334), PARP (Cell Signaling Technology Cat# 9532, RRID:AB_659884), OGT (Cell Signaling Technology Cat# 24083, RRID:AB_2716710), His-tag (Cell Signaling Technology Cat# 12698, RRID:AB_2744546), FLAG-tag (Cell Signaling Technology Cat# 14793, RRID:AB_2572291), Myc-tag (Cell Signaling Technology Cat# 2276, RRID:AB_331783), HA-tag (Cell Signaling Technology Cat# 3724, RRID:AB_1549585), Cyclin D1 (Cell Signaling Technology Cat# 55506, RRID:AB_2827374), RUNX1 (Cell Signaling Technology Cat# 4336, RRID:AB_10859035) were all from Cell signaling technology; the antibody against PDGFB (Santa Cruz Biotechnology Cat# sc-365805, RRID:AB_10848458) was from Santa Cruz; the antibodies against O-GlcNAc (RL2) (Abcam Cat# ab2739, RRID:AB_303264) and RUNX1 (Abcam Cat #ab240639) were from Abcam. .. Plasmid expressing HA-RUNX1 RRID:Addgene_181980 was from Addgene; Generated:Article Title: Stabilization of RUNX1 Induced by O-GlcNAcylation Promotes PDGF-BB-Mediated Resistance to CDK4/6 Inhibitors in Breast Cancer Article Snippet: The antibodies against phospho-Rb (Ser 807/811) (Cell Signaling Technology Cat# 8516, RRID:AB_11178658), total-Rb (Cell Signaling Technology Cat# 9309, RRID:AB_823629), phosphor-Akt (Ser473) (Cell Signaling Technology Cat# 4060, RRID:AB_2315049), total-Akt (Cell Signaling Technology Cat# 9272, RRID:AB_329827), p21 (Cell Signaling Technology Cat# 2947, RRID:AB_823586), GAPDH (Cell Signaling Technology Cat# 2118, RRID:AB_561053), β-Actin (Cell Signaling Technology Cat# 3700, RRID:AB_2242334), PARP (Cell Signaling Technology Cat# 9532, RRID:AB_659884), OGT (Cell Signaling Technology Cat# 24083, RRID:AB_2716710), His-tag (Cell Signaling Technology Cat# 12698, RRID:AB_2744546), FLAG-tag (Cell Signaling Technology Cat# 14793, RRID:AB_2572291), Myc-tag (Cell Signaling Technology Cat# 2276, RRID:AB_331783), HA-tag (Cell Signaling Technology Cat# 3724, RRID:AB_1549585), Cyclin D1 (Cell Signaling Technology Cat# 55506, RRID:AB_2827374), RUNX1 (Cell Signaling Technology Cat# 4336, RRID:AB_10859035) were all from Cell signaling technology; the antibody against PDGFB (Santa Cruz Biotechnology Cat# sc-365805, RRID:AB_10848458) was from Santa Cruz; the antibodies against O-GlcNAc (RL2) (Abcam Cat# ab2739, RRID:AB_303264) and RUNX1 (Abcam Cat #ab240639) were from Abcam. .. Plasmid expressing HA-RUNX1 RRID:Addgene_181980 was from Addgene; |